Global Intrauterine Devices Market is expected to grow considerably through 2032 owing to the increasing preference for planned delayed pregnancy.

However, the high cost of intrauterine devices as compared to the other cost-effective alternatives has put a strain on the overall market growth. In light of the increased prevalence of unwanted births, growing abortion rates, health degradation, and other factors, governments are working on expanding their capabilities by raising knowledge and offering IUDs as a contraceptive option to women. Its low adoption rate, particularly in developing areas, is hampered by its high acquisition costs.

On the other hand, the increasing usage of intrauterine devices can be credited to the rising incidence of unwanted pregnancies and the adverse effects associated with alternative contraceptive methods, such as oral pills, which has favorably impacted market growth.

Leading companies are creating new and advanced options for preventing pregnancies to score a competitive edge in the market. For instance, in August 2021, Bayer AG received FDA approval for an upgrade of the Intrauterine Device (IUD) Mirena 52 mg for a maximum of seven years of preventing pregnancy. The approval has enabled the company to enhance its intrauterine device product line, resulting in increased revenue creation.

The intrauterine devices market has been bifurcated in terms of product, age group, and region.

Based on the age group, the 20-24 age segment is slated to grow at 6% CAGR from 2023 to 2032. Young adult women are increasingly using IUDs due to awareness campaigns and additional health advantages provided by these devices. The prevalence of unwanted pregnancies among women may be reduced using long-acting contraception including hormonal intrauterine devices (IUDs) and coppers, fostering the production adoption amongst young population.

From the regional perspective, the North America intrauterine devices market is speculated to witness notable expansion by 2032. The high market position held by North America can be credited to a variety of factors, including growing public knowledge of innovative contraceptive methods including IUDs, which have resulted in an immediate drop in unplanned pregnancies in the region. According to a National Center of Biotechnology Information (NCBI) report, approximately 1 million abortions take place in the United States each year. Also, approximately 70% of female family planning recipients in the United States used some kind of contraception between 2017 and 2019.